Astellas Pharma Company Description
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer.
It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants.
Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex’s GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution.
Astellas Pharma Inc. was formerly known as Yamanouchi Pharmaceutical Co. Ltd. and changed its name to Astellas Pharma Inc. in April 2005.
The company was founded in 1923 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1923 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 13,643 |
| CEO | Naoki Okamura |
Contact Details
Address: 2-5-1, Nihonbashi-Honcho Tokyo, 103-8411 Japan | |
| Phone | 81 3 3244 3000 |
| Website | astellas.com |
Stock Details
| Ticker Symbol | ALPMY |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | US04623U1025 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Naoki Okamura BSc | President, Chief Executive Officer and Director |
| Atsushi Kitamura | Senior Executive Officer and Chief Financial Officer |
| Nobue Yasuda | General Manager of Finance and Accounting Department |
| Yoshitsugu Shitaka Ph.D. | Chief Scientific Officer and Senior Managing Executive Officer |
| Tatjana Dragovic J.D. | General Counsel, Chief Ethics and Compliance Officer |
| Katsuyoshi Sugita | Chief People Officer, Chief Ethics and Compliance Officer, Executive Vice President of Human Resources and Representative Director |
| Stig Ogata | Vice President of Corporate Communications |
| Nobuaki Tanaka | President of Japan Commercial and Senior Corporate Executive |
| Jun Kono | Senior Executive Officer and Head of Japan Commercial |
| Leticia Delgado-Herrera | Vice President and Rx+ M&D Head |